Table of Contents

company-logo

Medesis Pharma S.A., a clinical development stage biopharmaceutical company, engages in the development of orally administered molecule drug candidates to address unmet medical needs. Its products include NanoLithium (NP03), a clinical stage development product for the treatment of Alzheimer's disease; NanosiRNA DH for the treatment of Huntington's Disease; NU01 Plutonium and NU02 Cesium decorporation products for nuclear decorporation; a radioprotection drug to treat people irradiated following a civil or military nuclear accident (NP02 – NanoManganese); NanosiRNA COVID-19, an antiviral treatment solution for viral diseases; and NanosiRNA Resistant cancers and NanosiRNA Oncolytic virus for the treatment of oncology. The company was founded in 2003 and is based in Montpellier, France.

Medesis Pharma Dividend Announcement

• Medesis Pharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Medesis Pharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Medesis Pharma Dividend History

Medesis Pharma Dividend Yield

Medesis Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Medesis Pharma stock? Use our calculator to estimate your expected dividend yield:

Medesis Pharma Financial Ratios

P/E ratio-0.68
PEG ratio0.09
P/B ratio-0.47
ROE81.53%
Payout ratio0.00%
Current ratio0.38
Quick ratio0.34
Cash Ratio0.01

Medesis Pharma Dividend FAQ

Does Medesis Pharma stock pay dividends?
Medesis Pharma does not currently pay dividends to its shareholders.
Has Medesis Pharma ever paid a dividend?
No, Medesis Pharma has no a history of paying dividends to its shareholders. Medesis Pharma is not known for its dividend payments.
Why doesn't Medesis Pharma pay dividends?
There are several potential reasons why Medesis Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Medesis Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Medesis Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Medesis Pharma a dividend aristocrat?
Medesis Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Medesis Pharma a dividend king?
Medesis Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Medesis Pharma a dividend stock?
No, Medesis Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Medesis Pharma stocks?
To buy Medesis Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Medesis Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.